Aardvark released exploratory data from its stopped Phase 3 HERO trial in Prader-Willi syndrome after FDA lifted the hold, and plans a redesigned Phase 3.
|Articles|December 15, 2022
People and Business News — 12/22
Advertisement
People News
Worldwide Clinical Trials announced the appointment of Pete Duprat as Senior Vice President, Commercial, Early Phase.
IDDI announced the appointment of a new CEO, Linda Danielson.
Signant Health announced the appointment of Graciela Racaro to the position of chief operating officer.
CluePoints, has announced Andy Cooper has been appointed as its new Chief Executive Officer.
Veeva Systems and CDISC announce that Dan Crawford, Veeva Clinical Database principal consultant, has been elected chair of the CDISC Advisory Council.
Emmes announced that Ching Tian has joined the company as chief innovation officer Additonally the comapny has hired Wendy Buckland as Chief Operating Officer.
Business News
Quanticate announced plans for further expansion and new jobs in 2023 as it thrives post-pandemic.
physIQ announced that OncoBay Clinical, Inc., has joined the Intrepid Partner Program.
Catalent announced that it has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone in Shanghai, China.
Almac Clinical Technologies has been ranked as the industry’s most preferred IRT application globally, among recent users in a recent independent survey for their Interactive Response Technology software, IXRS 3.
Recognition
4G Clinical announced it ranked No. 159 on the Deloitte Technology Fast 500.
OKRA.ai won the Deloitte UK Fast 50 Women in leadership award and also ranked 9th in the Deloitte Technology Fast 500.
Advertisement
Related to this article
Clinical trials capture data faster than ever, but the real bottleneck is the distance between data capture and a decision teams can trust.
In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
2
Clinical Trials Do Not Have a Data Problem, They Have a Decision-Readiness Problem
3
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
4
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
5